Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Kammula US"" wg kryterium: Autor


Tytuł :
In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy.
Autorzy :
Giehl E; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.; Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Dresden, Germany.
Kosaka H; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.; Oncology Research Laboratories Oncology R&D Unit, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Liu Z; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Feist M; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.; Department of Surgery, CCM/CVK, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kammula US; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Lotze MT; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Ma C; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Guo ZS; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Bartlett DL; Departments of Surgery, University of Pittsburgh School of Medicine, and UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 18; Vol. 12, pp. 610042. Date of Electronic Publication: 2021 Feb 18 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy, Adoptive*/adverse effects
Immunotherapy, Adoptive*/methods
Genetic Vectors/*adverse effects
Lymphocyte Activation/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Lymphocytes, Tumor-Infiltrating/*metabolism
Oncolytic Viruses/*immunology
Peritoneal Neoplasms/*therapy
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Genetic Vectors/genetics ; Humans ; Immunophenotyping ; Interleukin-15/metabolism ; Interleukin-15 Receptor alpha Subunit/metabolism ; Mice ; Oncolytic Virotherapy/adverse effects ; Oncolytic Viruses/genetics ; Peritoneal Neoplasms/secondary ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance.
Autorzy :
Guo W; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Wang Y; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Yang M; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Wang Z; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Wang Y; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Chaurasia S; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
Wu Z; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Zhang M; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Yadav GS; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
Rathod S; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Concha-Benavente F; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Fernandez C; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Li S; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Xie W; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Ferris RL; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Kammula US; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
Lu B; Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Yang D; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA. .; UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2021 Feb 10; Vol. 7 (7). Date of Electronic Publication: 2021 Feb 10 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies